NCM·Healthcare·$335M·#226 / 520 in Healthcare
CLPT ClearPoint Neuro Inc.
49SPECULATIVE
CATEGORY BREAKDOWN
GROWTH28
QUALITY52
STABILITY55
VALUATION50
GOVERNANCE56
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+17.8%
28
> 50% strong
Gross Margin
Revenue retained after direct costs
61.4%
87
> 50% strong
Cash Runway
Months of cash at current burn rate
23 months
82
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
207.8%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
9.1x
50
< 3x strong
Rule of 40
Growth rate plus operating margin
-48
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
8.2%
56
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+7.2%
57
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CLPT WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CLPT's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.